Axsome Therapeutics COO sells shares for $5.2 million
NeutralFinancial Markets

The COO of Axsome Therapeutics has sold shares worth $5.2 million, a move that raises questions about the company's future direction. While such transactions are common in the corporate world, they can signal confidence or concern among investors. This sale could impact stock performance and investor sentiment, making it a noteworthy event in the biotech sector.
— Curated by the World Pulse Now AI Editorial System